University of Sussex invites applications for a 3-year MSCA Doctoral Candidate to investigate β-catenin inhibitors on normal hematopoietic development, Wnt signaling, and AML. The project integrates safety and efficacy testing across preclinical models, with secondments and international collaboration.
Applicants should hold a science Master’s degree, demonstrate excellent English, and be motivated for multidisciplinary doctoral research with publication goals and active dissemination of results.
#J-18808-Ljbffr…
